Inspire Medical Systems Inc
Research Inspire Medical Systems Inc (INSP) on Bullrun: market cap USD 1.77B, P/E 13.3. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerINSP
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 1.77B
- P/E13.3
- Financial periodQ2 2026
- RevenueUSD 200.58M
- Net incomeUSD 314.00K
- Free cash flowUSD 14.07M
- Gross margin85.5%
Valuation Snapshot
latest market cap is USD 1.77B; P/E is 13.3.
Peer valuation comparison
Latest P/E is 13.26x versus a Healthcare sector median of 24.46x (45.8% below).
Latest P/E is 13.26x versus a United States median of 24.87x (46.7% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 911.98M | USD 145.42M | USD 78.48M | 85.4% | 4.89 | USD 104.81M | USD 32.16M | USD 781.16M |
| FY2024 | USD 802.80M | USD 53.51M | USD 91.12M | 84.7% | 1.75 | USD 150.15M | USD 31.79M | USD 689.70M |
| FY2023 | USD 624.80M | -USD 21.15M | USD 1.02M | 84.5% | -0.72 | USD 185.54M | USD 24.85M | USD 572.51M |
| FY2022 | USD 407.86M | -USD 44.88M | USD 2.47M | 83.8% | -1.6 | USD 441.59M | USD 31.34M | USD 496.01M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.77B | 13.3 | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.64B | 18.6 | n/a | n/a |
| 2024 | 2024-12-31 | USD 5.51B | 107.2 | n/a | n/a |
| 2023 | 2023-12-29 | USD 6.01B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 7.28B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 6.31B | n/a | n/a | n/a |
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Inspire Medical Systems Inc's market cap?
Inspire Medical Systems Inc's market capitalization is USD 1.77B.
What is Inspire Medical Systems Inc's P/E ratio?
Inspire Medical Systems Inc's price-to-earnings (P/E) ratio is 13.3.
What does Inspire Medical Systems Inc do?
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.